The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Several studies have evaluated the association between individual polymorphisms and response to methylphenidate (MPH) in subjects with attention‐deficit/hyperactivity disorder (ADHD). There are few replication studies for each polymorphism of interest and results are sometimes inconsistent in this field. Although data collection from multiple international sites would allow large sample sizes, this approach has been criticized for introducing sampling variability due to differences in ethnicity and methodology between studies. To examine these issues, we aggregated nine pharmacogenetic studies from four different continents and conducted a two stage analysis: (a) we evaluated the role of methodological aspects in the variability of ADHD symptom improvement between studies using meta‐regression analysis; (b) we assessed the role of individual characteristics of the subjects in the variability of ADHD symptoms improvement using multivariate regression analysis in the same data sets. At the study level, from five evaluated factors, only the design of the study (open studies vs. randomized controlled trials) was significantly associated with heterogeneity of results (P = 0.001). At the individual level, age (P < 0.001), comorbid oppositional defiant disorder (P < 0.001), and pre‐treatment scores (P < 0.001) were associated with change of ADHD scores with treatment in the final multivariate model. Our results suggest that joint analyses of pharmacogenetic studies are feasible and promising, since fixed variables, such as the site where the study was conducted, were not related to results. Nevertheless, stratified analyses according to the design of the study must be preferentially conducted and the role of individual factors such as demographic data and comorbid profile as confounders should be assessed. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KESSLER, R. C., ADLER, L., AMES, M., DEMLER, O., FARAONE, S., HIRIPI, E., HOWES, M. J., JIN, R., SECNIK, K., SPENCER, T., et al. (2005) · Psychological Medicine · doi:10.1017/s0033291704002892 · Cited by 3,452 · cited 1×
“World Health Organization Adult ADHD Self-Report Scale [Kessler et al., 2005]; ADHD-RS: ADHD Rating-Scale [DuPaul et al.”
MethodSelf-citationMolecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357
Self-citationMeta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
SWANSON, J. M., KRAEMER, H. C., HINSHAW, S. P., ARNOLD, L. E., CONNERS, C. K., ABIKOFF, H. B., CLEVENGER, W., DAVIES, M., ELLIOTT, G. R., GREENHILL, L. L., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00011 · Cited by 1,157
ADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups
JENSEN, P. S., HINSHAW, S. P., KRAEMER, H. C., LENORA, N., NEWCORN, J. H., ABIKOFF, H. B., MARCH, J. S., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00009 · Cited by 974 · cited 1×
“However, the comorbid subgroup presented persistent differences at the end-point, indicating a less favorable prognosis [Jensen et al., 2001].”
BackgroundMolecular Genetics of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Mick, E. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.004 · Cited by 411 · cited 2×
“These studies focused mainly on genes believed to be associated with the disease [Faraone et al., 2005], predominantly from the dopaminergic system [Roman et al., 2002; Stein et al., 2005; Mick et al., 2006; Cheon et al., 2007; Kooij et al., 2008], but also from the noradrenergic [Polanczyk et al.,…”
BackgroundSelf-citationFaraone, S. V., Spencer, T., Aleardi, M., Pagano, C., & Biederman, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000108984.11879.95 · Cited by 404 · cited 6×
“, 2007a) and in methylphenidate’s effect size (Faraone et al., 2006; Faraone et al., 2004).”
BackgroundMethodResultSelf-citationBUITELAAR, J. K., VAN DER GAAG, R. J., SWAAB-BARNKVHLD, H., & KUIPKR, M. A. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199508000-00012 · Cited by 160
Self-citationEffects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD
Arnold, L. E., Elliott, M., Sachs, L., Bird, H., Kraemer, H. C., Wells, K. C., Abikoff, H. B., Comarda, A., Conners, C. K., Elliott, G. R., et al. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.4.713 · Cited by 159 · cited 2×
“These findings are in the same direction of those from the National Institute of Mental Health Multimodal Treatment Study of ADHD (MTA), which detected a substantial and clinically similar response to MPH between African Americans, Latinos, and Caucasians [Arnold et al., 2003].”
ResultReinhardt, M. C., Benetti, L., Victor, M. M., Grevet, E. H., Belmonte-de-Abreu, P., Faraone, S. V., & Rohde, L. A. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0720 · Cited by 36 · cited 3×
“Guilherme Polanczyk,1,2 Stephen V. Faraone,3 Claiton H.D. Bau,4,5 Marcelo M. Victor,5 Katja Becker,6,7 Reta Pelz,6 Jan K. Buitelaar,8 Barbara Franke,8,9 Sandra Kooij,10 Emma van der Meulen,11 Keun-Ah Cheon,12 Eric Mick,13 Diane Purper-Ouakil,14,15 Philip Gorwood,15,16 Mark A. Stein,17 Edwin H. Cook Jr.,17 and Luis Aug…”
BackgroundSelf-citation
Cited by
Young, S., Adamo, N., Ásgeirsdóttir, B. B., Branney, P., Beckett, M., Colley, W., Cubbin, S., Deeley, Q., Farrag, E., Gudjonsson, G., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02707-9 · Cited by 610
Capusan, A. J., Bendtsen, P., Marteinsdottir, I., & Larsson, H. (2019) · Journal of Attention Disorders · doi:10.1177/1087054715626511 · Cited by 122
Kambeitz, J., Romanos, M., & Ettinger, U. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.9 · Cited by 64
Contini, V., Victor, M. M., Marques, F. Z. C., Bertuzzi, G. P., Salgado, C. A. I., Silva, K. L., Sousa, N. O., Grevet, E. H., Belmonte-de-Abreu, P., & Bau, C. H. D. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-009-0362-2 · Cited by 27
“123 results ( Polanczyk et al. 2005, 2008 ). Some of the positive findings could actually be spurious, especially due to inadequate sample sizes.”
BackgroundSelf-citationGomez-Sanchez, C. I., Carballo, J. J., Riveiro-Alvarez, R., Soto-Insuga, V., Rodrigo, M., Mahillo-Fernandez, I., Abad-Santos, F., Dal-Ré, R., & Ayuso, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-10912-y · Cited by 24
Elsayed, N. A., Yamamoto, K. M., & Froehlich, T. E. (2020) · CNS Drugs · doi:10.1007/s40263-020-00702-y · Cited by 23
Metadata
- Authors
- Polanczyk, G., Faraone, S. V., Bau, C. H. D., Victor, M. M., Becker, K., Pelz, R., Buitelaar, J. K., Franke, B., Kooij, S., van der Meulen, E., Cheon, K., Mick, E., Purper‐Ouakil, D., Gorwood, P., Stein, M. A., Cook, E. H., & Rohde, L. A.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2008-09-18
- Volume
- 147B
- Issue
- 8
- Pages
- 1419-1424
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2077615326
- Cited by
- 32
- References
- 10
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.